HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: clinchem.2008.116038v1 54/12/1948    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Westhoff, C. M. Articles by Sloan, S. R. Search for Related Content PubMed PubMed Citation Articles by Westhoff, C. M. Articles by Sloan, S. R.

Molecular Genotyping in Transfusion Medicine

¹ American Red Cross and Department of Pathology and Laboratory Medicine, Division of Transfusion Medicine, University of Pennsylvania, Philadelphia, PA; ² Joint Program in Transfusion Medicine, Department of Laboratory Medicine, Children’s Hospital Boston and Harvard Medical School, Boston, MA.

^aAddress correspondence to this author at: 700 Spring Garden St., Philadelphia, PA 19123. Fax 215-451-4925; e-mail westhoffc@usa.redcross.org.

The first 300 words of the full text of this article appear below.

"Blood-Matching Goes Genetic," a recent News Focus article in Science (1), illustrates the growing awareness of the impact of the genomics revolution on transfusion medicine and its potential to transform the way blood is selected for transfusion. Antibody-based technology has been the basis for blood group typing since the discovery of the ABO blood groups by Landsteiner and colleagues. With the availability of single-nucleotide polymorphism (SNP)¹ genotyping, the blood bank is poised to become one of the primary laboratory disciplines to benefit from the PCR-technology revolution.

DNA-testing methods are applicable to transfusion medicine because the genes encoding blood group antigens and the genetic polymorphisms associated with the antigens are known. Similar to many disease markers, most of the antigens in blood groups result from SNPs inherited in a straightforward Mendelian manner. SNPs account for much of human genome diversity, and the ability to link SNPs to disease or disease risk, and even to individual variation in drug responses, makes SNP profiling a technology likely to contribute to fulfilling the promise of personalized medicine. The appreciation of this potential has fueled the development of high-throughput SNP-genotyping platforms, which are currently being applied in the prediction of blood group antigens (2). The use of such platforms enables rapid, cost-effective screening for multiple clinically significant blood groups in a single assay. The field of transfusion medicine can now consider individualized transfusion treatment, i.e., matching donors with patients at multiple blood group loci in addition to the ABO and RhD systems. This approach holds promise for reducing, and potentially eliminating, alloimmunization.

Expanded Typing

SNP typing allows the evaluation of blood group antigens in circumstances in which it is not possible with antibody-based methods. For example, in patients receiving chronic or massive transfusions, the presence of donor red blood cells (RBCs) makes typing . . . [Full Text of this Article]

Prenatal Testing

Maternal D Determination

Considerations

Alloimmunization Risk and Inventory Management

Conclusions